news
UK research consortium given £2 million to control monkeypox
£2 million will help fund a UK team of scientific experts to research monkeypox, uncover novel treatments and curb the spread of the virus.
List view / Grid view
Smallpox
news
US begins monkeypox vaccine and therapeutic trials
US National Institutes of Health initiates trials to evaluate antiviral tecovirimat (TPOXX) and possibility of delivering Jynneos vaccine intradermally.
article
Monkeypox update – August 2022
In this article, EPR’s Hannah Balfour discusses the recent multi-country monkeypox outbreak, highlighting key developments in the international response.
news
Bavarian Nordic to supply EU Member States with monkeypox vaccine
Bavarian Nordic has announced it will supply 110,000 doses of its MVA-BN smallpox/monkeypox vaccine to the European Health Emergency Preparedness and Response Authority (HERA) over the coming months.
news
Bavarian Nordic signs supply contract for smallpox vaccine as monkeypox cases rise
The agreement between Bavarian Nordic and an undisclosed country aims to ensure sufficient supply of smallpox vaccine to meet the country’s requirements for vaccinating individuals at risk for monkeypox.
news
Vaccine delivered via skin scarification could help fight respiratory diseases
According to a new study, vaccines delivered via skin scarification were better at inducing T cell activity in pre-clinical animal models.
article
How to improve vaccine procurement strategies to optimise coverage in Europe
Tim Wilsdon and Ryan Lawlor from Charles River Associates explain why price-based procurement strategies can limit the long-term effectiveness and sustainability of vaccine programmes.
news
FDA approves vaccine for smallpox and monkeypox
The Jynneos live, non-replicating vaccination for smallpox and monkeypox has been approved by the FDA for high-risk patients.
news
FDA approves the first drug with an indication for treatment of smallpox
The US Food and Drug Administration has approved TPOXX (tecovirimat), the first drug with an indication for treatment of smallpox...
news
Bavarian Nordic receives bulk order for Imvamune smallpox vaccine
7 July 2015 | By Victoria White
BARDA, a division of the US Department of Health & Human Services, has ordered a bulk supply of Bavarian Nordic’s Imvamune non-replicating smallpox vaccine...
news
Bavarian Nordic announces positive results from pivotal Phase 3 study of IMVAMUNE smallpox vaccine
13 May 2015 | By Victoria White
Results from a Phase 3 study of the liquid-frozen formulation of IMVAMUNE support a Biologics License Application for US approval of the vaccine...
